Cameco Corporation stock leads 3-ETF growth picks riding nuclear and critical minerals demand.

Global economic indicators are sending mixed signals, with resilient manufacturing in parts of Europe and Asia alongside evolving inflation trends in North America and Europe, and ongoing cost pressures from commodities and energy. In this environment, investors increasingly seek companies where analysts still identify solid earnings growth potential combined with sound balance sheets. The Healthy high growth potential screener aims to capture exactly this dynamic, highlighting stocks where three-year earnings expectations align with financial stability.

**Cameco**

Cameco, a Saskatoon-based uranium and nuclear fuel company, mines, refines and converts uranium while supplying reactor technology, services and components to utilities across the Americas, Europe and Asia through its Westinghouse stake. The company generates approximately CA$3.0 billion in revenue from uranium, CA$3.6 billion from Westinghouse, and roughly CA$0.6 billion from fuel services.

Cameco's strength in this screener stems from its position at the center of the nuclear fuel supply chain. With tier-one uranium assets like Cigar Lake and a 49% stake in Westinghouse, the company stands to benefit significantly as governments in North America and Europe increase their emphasis on nuclear power. However, the stock trades at a very high price-to-earnings multiple and depends heavily on external borrowing. Project delays or operational issues at key mines could materially impact cash flows, raising questions about whether the nuclear narrative justifies both the risks and current valuation.

**Celestica**

Celestica, a Toronto-based electronics manufacturing and supply chain company, designs, builds and manages complex hardware platforms and related services for original equipment makers, cloud providers, hyperscalers and customers across aerospace, defense, industrial and health technology sectors. The company generates approximately US$3.2 billion in revenue from Advanced Technology Solutions and US$10.6 billion from Connectivity & Cloud Solutions.

Celestica occupies a central position in the AI infrastructure buildout, serving hyperscalers and cloud providers through its Connectivity & Cloud Solutions segment while also supplying higher-margin aerospace, industrial and health technology customers. Revenue and earnings growth have been strong, with analysts forecasting approximately 30% annual growth in both metrics and returns on equity of roughly 45.7%. This growth trajectory comes with significant trade-offs, including heavy reliance on a few large customers, a high price-to-earnings multiple and funding that depends entirely on external borrowing. For investors tracking AI-driven hardware developments, the combination of growth, margins and concentration risk warrants close monitoring.

**Energy Fuels**

Energy Fuels, based in Lakewood, Colorado, focuses on uranium, rare earth elements and heavy mineral sands, supplying materials for nuclear fuel, magnets and other critical technologies for U.S. and allied markets. The company currently reports essentially all of its US$84.6 million in segment revenue from uranium, with a minor US$0.3 million adjustment.

Energy Fuels has attracted attention by positioning itself at the intersection of nuclear fuel and critical minerals precisely as the U.S. invests in domestic supply chains. The company has secured up to US$725 million in conditional debt financing and plans a US$1.9 billion acquisition of VAC to develop a rare earth mining operation. Analysts have highlighted potential for revenue and earnings growth and a possible path to profitability within three years. Currently loss-making, the company carries a very high price-to-sales multiple and requires substantial funding and reliable feedstock to execute its rare earth expansion plans. Investors should carefully weigh how the combination of government backing, expansion projects and execution risk aligns with expectations reflected in the current valuation.

**Conclusion**

These three stocks represent only a starting point—the full Healthy high growth potential screener has identified 59 additional companies with similarly compelling growth and financial strength stories. The strongest opportunities rarely remain under the radar for long, making early identification critical for investors seeking to stay ahead of market shifts.